News
Towards precision medicine and gene therapy – a new AV21 Strategy programme
Czech Centre for Phenogenomics is coordinating a new research programme “Towards precision medicine and gene therapy” of the AV21 Strategy. Our programme benefits from the synergistic expertise of all partners and creates a multidisciplinary consortium covering the areas of gene editing, organic chemistry of nucleic acid delivery systems, preclinical models of human diseases, and starting with neurosciences… Read more
Mice and genetic scissors help Czech scientists seek treatment for “angelic” children
On the occasion of the International Day of Rare Diseases Czech Centre for Phenogenomics in collaboration with BIOCEV and Czech Academy of Sciences issued a press release summarizing their research in the area of rare diseases. The press release (in English) is available on the BIOCEV website. The press release (in Czech) is available on… Read more
Mouse models from the Czech Centre for Phenogenomics help in researching Angelman’s syndrome
We are celebrating the International Angelman Day on 15th February. Angelman’s syndrome is an inherited disease of the central nervous system that causes severe physical and mental disabilities. The team of the Czech Center for Phenogenomics is engaged in research of Angelman’s syndrome (and other rare diseases) on mouse models created by us or already… Read more
3rd Workshop IMPC mouse models contribution to current advances in metabolic and cardiac research
Registration form – participation is free of charge Read more
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
The emergence of new SARS-CoV-2 variants that harbor mutations in the viral S protein raised concern about activity of current vaccines and therapeutic antibodies. CCP participated in the research study aiming to find new tools for COVID-19 therapy based on the novel monoclonal antibodies. The results were recently published in EBioMedicine belonging to the Lancet… Read more
Czech-Swiss project “SARS-Cov-2: understanding the entry, multi-organ spread and immune response in the context of vaccination and re-infection” received funding.
Our collaboration with Luca Varani’s lab from the Institute for Research in Biomedicine in Bellinzona in Switzerland will expand thanks to the grants of the Czech and the Swiss Science Foundations. Both foundations decided to fund our joint project “SARS-Cov-2: understanding the entry, multi-organ spread and immune response in the context of vaccination and re-infection”… Read more
Scientific Advisory Board met virtually
On Friday 21st January 2022, the Scientific Advisory Board met virtually and discussed with CCP management the achievements of 2021 and future directions of the Centre for the period 2022-2029. Besides the traditional reports about 2021 outcomes in research services, research and development of new methodologies, the presented highlights focused on: Cardiovascular comprehensive screening for… Read more
New CCP e-Newsletter 2021
The first issue of our brand new online newsletter is available on https://phenogenomics.cz. We are delighted to share our recent achievements and updates on mouse phenogenomics, so from now on, the latest developments at CCP will be directly delivered to you via e-mail, with a dedicated website and interesting links for further reading. Enjoy reading… Read more
Season’s greetings and the best wishes for the New Year
We wish you all the best for the New Year and look forward to cooperating with you in 2022. Read more
CCP evaluated in the International peer-review of large research infrastructures in the Czech Republic in 2021
In the first half of 2021, the Ministry of Education, Youth and Sports organized an international peer-review of large research infrastructures in the Czech Republic, which results were published in December. The purpose of this evaluation was to obtain independent expert reviews about the performance of large research infrastructures. CCP confirmed its top level. According… Read more